These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33485848)

  • 1. Emerging physiological and pathological roles of MeCP2 in non-neurological systems.
    Wang J; Xiao Y; Liu C; Huang Y; Petersen RB; Zheng L; Huang K
    Arch Biochem Biophys; 2021 Mar; 700():108768. PubMed ID: 33485848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rett syndrome and MeCP2.
    Liyanage VR; Rastegar M
    Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P152R Mutation Within MeCP2 Can Cause Loss of DNA-Binding Selectivity.
    Franklin D
    Interdiscip Sci; 2019 Mar; 11(1):10-20. PubMed ID: 30673959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research.
    Zachariah RM; Rastegar M
    Neural Plast; 2012; 2012():415825. PubMed ID: 22474603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)-Implications for Parkinson's Disease and Rett Syndrome.
    Schmitt I; Evert BO; Sharma A; Khazneh H; Murgatroyd C; Wüllner U
    Mol Neurobiol; 2024 Oct; 61(10):7830-7844. PubMed ID: 38429622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
    Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
    Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The methyl-CpG-binding protein MeCP2 and neurological disease.
    Bird A
    Biochem Soc Trans; 2008 Aug; 36(Pt 4):575-83. PubMed ID: 18631120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal non-CG methylation is an essential target for MeCP2 function.
    Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
    Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mecp2-null mice provide new neuronal targets for Rett syndrome.
    Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
    PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving role of MeCP2 in Rett syndrome and autism.
    LaSalle JM; Yasui DH
    Epigenomics; 2009 Oct; 1(1):119-30. PubMed ID: 20473347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes.
    Ehrhart F; Coort SL; Cirillo E; Smeets E; Evelo CT; Curfs LM
    Orphanet J Rare Dis; 2016 Nov; 11(1):158. PubMed ID: 27884167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism.
    Vuu YM; Roberts CT; Rastegar M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 Dysfunction in Rett Syndrome and Neuropsychiatric Disorders.
    Chin EWM; Goh ELK
    Methods Mol Biol; 2019; 2011():573-591. PubMed ID: 31273722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic Studies in Mouse Models of Rett Syndrome: A Review.
    Sanfeliu A; Kaufmann WE; Gill M; Guasoni P; Tropea D
    Neuroscience; 2019 Aug; 413():183-205. PubMed ID: 31229631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MECP2, a multi-talented modulator of chromatin architecture.
    Della Ragione F; Vacca M; Fioriniello S; Pepe G; D'Esposito M
    Brief Funct Genomics; 2016 Nov; 15(6):420-431. PubMed ID: 27296483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites.
    Ghosh RP; Horowitz-Scherer RA; Nikitina T; Shlyakhtenko LS; Woodcock CL
    Mol Cell Biol; 2010 Oct; 30(19):4656-70. PubMed ID: 20679481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.